Dermira Stock Analysis, Valuation (NASDAQ:DERM)
Investors can watch the Amigobulls Dermira stock analysis video here. This video puts forward our latest analysis highlighting the pros and cons for DERM stock.
Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.
Dermira Inc Stock Rating 1.4/5
Amigobulls DERM stock analysis takes into account various financial ratios like relative valuation, Dermira revenue, growth and return on equity based on latest quarter 2018 Q2 financial statements. We also check Dermira dividend performance. Dermira valuation analysis is based on relative valuation multiples like PE ratio and price to sales ratio. Dermira stock rating encapsulates our opinion about the company based on the fundamentals.
Should you sell DERM stock?
- Dermira reported an average operating margin of -741.49 over the Last Twelve Months (LTM).
- Dermira posted an average Net loss of -761.8% in the last twelve months.
- The company does not have profits. Hence the PE ratio is meaningless for DERM stock.
- Dermira has a negative ROE (Return On Equity) of -150.1, indicating the company is not profitable.
Dermira Related Company Stock Videos
Amigobulls Dermira stock analysis helps investors in understanding how the company's fundamentals have performed in the last few quarters. The fundamentals of a company are vital to identify long-term investment opportunities.
Dermira revenue growth is an indicator of the demand for a company's products while profit margin is indicative of company's pricing power and pricing strategy. Along with fundamentals, investors can utilize technical analysis to get a better idea about the price trend of Dermira stock.